Sponsor intelligence · INDUSTRY
Clinical trials sponsored by
Stemline Therapeutics, Inc..
Real, source-linked trial activity for Stemline Therapeutics, Inc.: 2 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Oct 15, 2026. Source-linked, daily-refreshed.
PHASE1/PHASE2 1N/A 1
Newest Stemline Therapeutics, Inc. trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 1d ago | KATALYST-HEME-01: Study of the KAT6 Inhibitor MEN2312 in Heme Malignan | Ph 1/Ph 2 | NOT_YET_RECRUITING | ↗ |
| 51d ago | A Registry-study of ELZONRIS in Participants With BPDCN | N/A | RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Stemline Therapeutics, Inc. (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.